Replies to post #949 on Vascular Biogenics Ltd (VBLT)

[Oren1976]

There is no doubt the impression came from the ceo is fear. He is nervous and worried . The change in interim analysis trigger is just one example but I say again even if the ceo call me in the middle of night saying he thinks I should sell and it's going to fail I m not selling. The cliff type deterioration of avastin will take place eventually (unfortunately) in control and the advantage of vb111 will be prominent at that point . Inspire, Facebook sharing ... most of the people in these forums announced a war against rgbm and jump from treatment to treatment sometimes doing wrong decisions....with all the pain of reading what they go through I won't sell even if they call me . From many reasons that I mentioned in the past vb111 won't be just a success but a big success although if they used other drugs to combine or monotherapy the results be better